Mirai Medical, a Galway based cancer treatment start-up, is leading a consortium planning to invest €7.2 million in developing a better way to treat gastrointestinal cancer, as well as potentially treating all solid tumours. The company, founded by Dr Declan Soden, is leading a group that also includes Nasdaq listed Advanced Energy and three Irish universities – NUIG, UCC and Trinity in Dublin. About €4.78 million of the funding being invested in researching these new treatments was awarded last week under the state’s Disruptive Technology Innovation Fund (DTIF). This award will allow Mirai Medical to expand its ePORE platform a…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .